What are the week‑by‑week titration doses for captopril?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Week-by-Week Captopril Titration Schedule

Start captopril at 6.25-12.5 mg three times daily, then titrate to 25 mg three times daily over the first week, advancing to 50 mg three times daily by weeks 2-4, with the target maintenance dose of 50 mg three times daily reached within several weeks as tolerated. 1

Initial Dosing (Week 1)

For heart failure or post-MI patients:

  • Day 1: Single test dose of 6.25 mg 1
  • Days 2-7: 12.5 mg three times daily 2, 1
  • Monitor blood pressure, renal function, and potassium at 5-7 days 3

For hypertension without volume depletion:

  • Start at 25 mg three times daily 2, 1

Week 2-3 Titration

  • Increase to 25 mg three times daily if starting from lower dose 1
  • Recheck potassium and creatinine every 5-7 days during titration 3
  • For hypertension: may advance to 50 mg twice or three times daily if blood pressure not controlled 2

Week 4 and Beyond

  • Target dose: 50 mg three times daily (150 mg total daily) 2, 4, 1
  • After reaching 50 mg three times daily, delay further increases for at least 2 weeks to assess response 1
  • Maximum dose: 50 mg three times daily for most indications; up to 150 mg three times daily for severe hypertension (not to exceed 450 mg daily) 2, 1

Critical Monitoring Points

Check at each titration step:

  • Blood pressure (avoid if systolic <90 mmHg) 2
  • Serum creatinine (stop if increases >30% from baseline) 5
  • Serum potassium (avoid starting if >5.0 mEq/L) 6
  • Monitor 1-2 weeks after each dose increment 7, 5

Special Populations

Renal impairment: Use slower titration with 1-2 week intervals between increases; may require lower maintenance doses 1

Volume depleted patients: Start with 6.25 mg three times daily to minimize hypotension risk 2, 1

Post-MI with LV dysfunction: The evidence-based target from major trials (SAVE) was 50 mg three times daily (127 mg mean daily dose achieved) 3, 4

Common Pitfall

The most critical error is advancing doses too rapidly without adequate monitoring of renal function and potassium, particularly when combining with other RAAS inhibitors or in patients with baseline renal impairment. Always recheck labs 5-7 days after each dose change until stable 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.